90 related articles for article (PubMed ID: 28346821)
1. Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase.
Madia VN; Benedetti R; Barreca ML; Ngo L; Pescatori L; Messore A; Pupo G; Saccoliti F; Valente S; Mai A; Scipione L; Zheng YG; Tintori C; Botta M; Cecchetti V; Altucci L; Di Santo R; Costi R
ChemMedChem; 2017 Aug; 12(16):1359-1368. PubMed ID: 28346821
[TBL] [Abstract][Full Text] [Related]
2. Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase.
Costi R; Di Santo R; Artico M; Miele G; Valentini P; Novellino E; Cereseto A
J Med Chem; 2007 Apr; 50(8):1973-7. PubMed ID: 17348637
[TBL] [Abstract][Full Text] [Related]
3. Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases.
Ji Z; Clark RF; Bhat V; Matthew Hansen T; Lasko LM; Bromberg KD; Manaves V; Algire M; Martin R; Qiu W; Torrent M; Jakob CG; Liu H; Cole PA; Marmorstein R; Kesicki EA; Lai A; Michaelides MR
Bioorg Med Chem Lett; 2021 May; 39():127854. PubMed ID: 33631370
[TBL] [Abstract][Full Text] [Related]
4. Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells.
Fioravanti R; Tomassi S; Di Bello E; Romanelli A; Plateroti AM; Benedetti R; Conte M; Novellino E; Altucci L; Valente S; Mai A
Molecules; 2020 Jul; 25(14):. PubMed ID: 32650558
[TBL] [Abstract][Full Text] [Related]
5. Identification of structural features of 2-alkylidene-1,3-dicarbonyl derivatives that induce inhibition and/or activation of histone acetyltransferases KAT3B/p300 and KAT2B/PCAF.
Castellano S; Milite C; Feoli A; Viviano M; Mai A; Novellino E; Tosco A; Sbardella G
ChemMedChem; 2015 Jan; 10(1):144-57. PubMed ID: 25333655
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors.
Yang Y; Zhang R; Li Z; Mei L; Wan S; Ding H; Chen Z; Xing J; Feng H; Han J; Jiang H; Zheng M; Luo C; Zhou B
J Med Chem; 2020 Feb; 63(3):1337-1360. PubMed ID: 31910017
[TBL] [Abstract][Full Text] [Related]
7. 4-Pyridone-3-carboxylic acid as a benzoic acid bioisostere: Design, synthesis, and evaluation of EP300/CBP histone acetyltransferase inhibitors.
Kanada R; Suzuki T; Murata T; Miyazaki M; Shimada T; Kuroha M; Minami M; Higuchi S; Tominaga Y; Naito H
Bioorg Med Chem Lett; 2021 Nov; 51():128358. PubMed ID: 34534674
[TBL] [Abstract][Full Text] [Related]
8. Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
Lu W; Xiong H; Chen Y; Wang C; Zhang H; Xu P; Han J; Xiao S; Ding H; Chen Z; Lu T; Wang J; Zhang Y; Yue L; Liu YC; Zhang C; Yang Y; Jiang H; Chen K; Zhou B; Luo C
Bioorg Med Chem; 2018 Nov; 26(20):5397-5407. PubMed ID: 30297119
[TBL] [Abstract][Full Text] [Related]
9. Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cells.
Lenoci A; Tomassi S; Conte M; Benedetti R; Rodriguez V; Carradori S; Secci D; Castellano S; Sbardella G; Filetici P; Novellino E; Altucci L; Rotili D; Mai A
ChemMedChem; 2014 Mar; 9(3):542-8. PubMed ID: 24504685
[TBL] [Abstract][Full Text] [Related]
10. Naphthoquinone-mediated inhibition of lysine acetyltransferase KAT3B/p300, basis for non-toxic inhibitor synthesis.
Vasudevarao MD; Mizar P; Kumari S; Mandal S; Siddhanta S; Swamy MM; Kaypee S; Kodihalli RC; Banerjee A; Naryana C; Dasgupta D; Kundu TK
J Biol Chem; 2014 Mar; 289(11):7702-17. PubMed ID: 24469461
[TBL] [Abstract][Full Text] [Related]
11. Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent.
Hwang SY; Park SY; Hong JY; Lee SY; Shin JH; Na Y; Sohn MH; Yoon HG; Kwon Y
Chem Commun (Camb); 2020 Aug; 56(68):9795-9798. PubMed ID: 32701101
[TBL] [Abstract][Full Text] [Related]
12. The PHD finger of p300 influences its ability to acetylate histone and non-histone targets.
Rack JGM; Lutter T; Kjæreng Bjerga GE; Guder C; Ehrhardt C; Värv S; Ziegler M; Aasland R
J Mol Biol; 2014 Dec; 426(24):3960-3972. PubMed ID: 25158095
[TBL] [Abstract][Full Text] [Related]
13. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
14. Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.
Pardin C; Roy I; Chica RA; Bonneil E; Thibault P; Lubell WD; Pelletier JN; Keillor JW
Biochemistry; 2009 Apr; 48(15):3346-53. PubMed ID: 19271761
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis.
Ghosh AK; Varga J
J Cell Physiol; 2007 Dec; 213(3):663-71. PubMed ID: 17559085
[TBL] [Abstract][Full Text] [Related]
16. Cinnamoyl inhibitors of tissue transglutaminase.
Pardin C; Pelletier JN; Lubell WD; Keillor JW
J Org Chem; 2008 Aug; 73(15):5766-75. PubMed ID: 18582115
[TBL] [Abstract][Full Text] [Related]
17. Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity.
Hoffmann A; Barz T; Spengler D
Mol Cell Biol; 2006 Jul; 26(14):5544-57. PubMed ID: 16809786
[TBL] [Abstract][Full Text] [Related]
18. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
19. 4-Carbonyl-2,6-dibenzylidenecyclohexanone derivatives as small molecule inhibitors of STAT3 signaling pathway.
Ji P; Yuan C; Ma S; Fan J; Fu W; Qiao C
Bioorg Med Chem; 2016 Dec; 24(23):6174-6182. PubMed ID: 27816267
[TBL] [Abstract][Full Text] [Related]
20. Structure-based identification of drug-like inhibitors of p300 histone acetyltransferase.
Zeng FQ; Peng SM; Li L; Mu LB; Zhang ZH; Zhang ZY; Huang N
Yao Xue Xue Bao; 2013 May; 48(5):700-8. PubMed ID: 23888693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
